MY101204A - Solubilization of protein aggregates - Google Patents

Solubilization of protein aggregates

Info

Publication number
MY101204A
MY101204A MYPI86000197A MYPI19860197A MY101204A MY 101204 A MY101204 A MY 101204A MY PI86000197 A MYPI86000197 A MY PI86000197A MY PI19860197 A MYPI19860197 A MY PI19860197A MY 101204 A MY101204 A MY 101204A
Authority
MY
Malaysia
Prior art keywords
protein
solubilization
protein aggregates
source
cationic surfactant
Prior art date
Application number
MYPI86000197A
Other languages
English (en)
Inventor
Roy Brandon Malcolm
John Patroni Joseph
Original Assignee
Natinco Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natinco Nv filed Critical Natinco Nv
Publication of MY101204A publication Critical patent/MY101204A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MYPI86000197A 1985-12-11 1986-12-11 Solubilization of protein aggregates MY101204A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH381885 1985-12-11

Publications (1)

Publication Number Publication Date
MY101204A true MY101204A (en) 1991-08-17

Family

ID=3771404

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI86000197A MY101204A (en) 1985-12-11 1986-12-11 Solubilization of protein aggregates

Country Status (14)

Country Link
US (1) US4797474A (2)
EP (1) EP0226448B1 (2)
JP (1) JPH0660198B2 (2)
CN (1) CN86108729A (2)
AT (1) ATE76878T1 (2)
AU (1) AU597924B2 (2)
CA (1) CA1281849C (2)
DE (1) DE3685562T2 (2)
DK (1) DK171331B1 (2)
ES (1) ES2032194T3 (2)
GR (1) GR3004903T3 (2)
MY (1) MY101204A (2)
NO (1) NO864990L (2)
NZ (1) NZ218586A (2)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
CA1305285C (en) * 1987-04-21 1992-07-14 Malcolm Roy Brandon Production of proteins in active forms
US4931543A (en) * 1987-05-11 1990-06-05 Cetus Corporation Process for recovering microbially produced interleukin-2
US5654176A (en) * 1987-05-28 1997-08-05 Amrad Corporation Limited Fusion proteins containing glutathione-s-transferase
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0295859B1 (en) * 1987-06-15 1994-11-17 Southern Cross Biotech Pty.Ltd. Production of proteins in active forms
US5266205A (en) * 1988-02-04 1993-11-30 Battelle Memorial Institute Supercritical fluid reverse micelle separation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
EP0444441B1 (en) * 1990-03-01 1996-09-25 Hewlett-Packard Company Minimizing eluate band widths in liquid chromatography
US5530100A (en) * 1990-05-07 1996-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Methods for purification of recombinantly produced proteins
DE69222384T2 (de) * 1991-08-26 1998-04-02 Hewlett Packard Co Palo Alto Chromatographisches Verfahren mit micellarer Anreicherung in der Säule
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
JP2000516210A (ja) 1996-07-12 2000-12-05 ロイコサイト，インコーポレーテッド ケモカインレセプターアンタゴニストとその使用方法
ZA9711733B (en) 1996-12-31 1998-07-01 Monsanto Co Method for solubilization and naturation of somatotropins
US20020052026A1 (en) 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
ES2245114T3 (es) 1998-08-06 2005-12-16 Mountain View Pharmaceuticals, Inc. Conjugados de peg-oxidasa de urato y su uso.
US7319021B2 (en) * 2002-11-01 2008-01-15 Promega Corporation Cell lysis composition, methods of use, apparatus and kit
DE10309691B4 (de) 2003-02-28 2018-10-04 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Gewinnung von löslichen Proteinen aus der Biomasse rekombinanter Mikroorganismen
WO2006110761A2 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. A variant form of urate oxidase and use thereof
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
TWI418564B (zh) * 2005-04-11 2013-12-11 Savient Pharmaceuticals Inc 利用陽離子界面活性劑之蛋白質純化
HUE052976T2 (hu) 2005-04-11 2021-06-28 Horizon Pharma Rheumatology Llc Urát-oxidáz variáns formái és azok alkalmazása
WO2006125452A1 (en) * 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
WO2007069673A1 (ja) * 2005-12-14 2007-06-21 Denka Seiken Co., Ltd. 多剤耐性ブドウ球菌のイムノクロマトグラフィー検出法および診断キット
CN101622270B (zh) 2006-04-12 2014-01-01 萨文特医药公司 用阳离子表面活性剂纯化蛋白质的方法
EP2074223A4 (en) * 2006-09-15 2010-03-10 Foldrx Pharmaceuticals Inc TEST PROCEDURE FOR THE DETECTION OF PROTEINS IN THE NATIVE CONDITION AND FOR THE IDENTIFICATION OF THE STABILITY OF PROTEINS IN THE NATIVE CONDITION MODULATING COMPOUNDS
US8663725B2 (en) * 2007-10-05 2014-03-04 Advance International Inc. Method for deriving a high-protein powder/ omega 3 oil and double distilled water from any kind of fish or animal ( protein)
US9706787B2 (en) * 2007-10-05 2017-07-18 Advance International Inc. Systems and methods for deriving protein powder
HUP1200205A3 (en) 2009-06-25 2012-09-28 Savient Pharmaceuticals Method and kits for perdicting infusion reaction risk and antibody-mediated low of response by monitoring serum uric acid during pegylated uricare therapy
SG10201606990TA (en) * 2012-05-31 2016-10-28 Agency Science Tech & Res Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives
US9826757B2 (en) 2013-03-15 2017-11-28 Advance International Inc. Automated method and system for recovering protein powder meal, pure omega 3 oil and purified distilled water from animal tissue
JP6147340B2 (ja) * 2013-05-29 2017-06-14 Jsr株式会社 洗浄用組成物、タンパク質精製方法、及びタンパク質
KR20160127087A (ko) * 2014-02-27 2016-11-02 에이전시 포 사이언스, 테크놀로지 앤드 리서치 알킬 양이온들로의 처리에 의한 단백질 제제들 내의 크로마틴 함량을 감소시키기 위한 방법들
CA2920789C (en) 2015-06-04 2021-05-18 Advance International, Inc. Improved methods and systems for recovering protein powder and natural omega-3 oil from animal tissue
CN110234340A (zh) 2016-11-11 2019-09-13 好利恩风湿病制药有限责任公司 泼尼松和尿酸酶分子的组合疗法及其用途
US20200237881A1 (en) 2019-01-30 2020-07-30 Horizon Pharma Rheumatology Llc Reducing immunogenicity to pegloticase
JP6984828B2 (ja) * 2017-11-22 2021-12-22 学校法人東京薬科大学 凝集タンパク質の再生剤およびこれを用いた凝集タンパク質の再生方法
US12121566B2 (en) 2019-01-30 2024-10-22 Horizon Therapeutics Usa, Inc. Methods for treating gout
US12269875B2 (en) 2023-08-03 2025-04-08 Jeff R. Peterson Gout flare prevention methods using IL-1BETA blockers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US4659568A (en) * 1985-02-27 1987-04-21 American Cyanamid Company Process for solubilization, purification and characterization of protein from insoluble protein aggregates or complexes and compositions of matter therefrom
US4656255A (en) * 1985-09-09 1987-04-07 International Minerals & Chemical Corp. Protein recovery
ATE60595T1 (de) * 1986-07-28 1991-02-15 Allied Signal Inc Sulfonierte benzotriazole und ihre verwendung in polyamiden.

Also Published As

Publication number Publication date
JPS62223192A (ja) 1987-10-01
NO864990L (no) 1987-06-12
DK592186A (da) 1987-06-12
EP0226448B1 (en) 1992-06-03
AU6687486A (en) 1987-06-18
EP0226448A3 (en) 1989-01-11
DE3685562D1 (de) 1992-07-09
DK171331B1 (da) 1996-09-09
DK592186D0 (da) 1986-12-10
CN86108729A (zh) 1987-10-21
AU597924B2 (en) 1990-06-14
US4797474A (en) 1989-01-10
JPH0660198B2 (ja) 1994-08-10
NO864990D0 (no) 1986-12-10
ATE76878T1 (de) 1992-06-15
CA1281849C (en) 1991-03-19
ES2032194T3 (es) 1993-01-16
EP0226448A2 (en) 1987-06-24
GR3004903T3 (2) 1993-04-28
DE3685562T2 (de) 1992-12-24
NZ218586A (en) 1989-07-27

Similar Documents

Publication Publication Date Title
MY101204A (en) Solubilization of protein aggregates
DK322188A (da) Fremgangsmaade til fremstilling af protein
FI881237A7 (fi) Menetelmä dispersioiden ja emulsioiden valmistamiseksi.
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
DE3779540D1 (de) Verzoegerungsschaltung zum elektrischen sprengen, zuender mit verzoegerungsschaltung und verfahren zum elektrischen sprengen von zuendern.
EP0303033A3 (en) Molecular cloning and characterization of a further gene sequence coding for human relaxin
ZA833668B (en) Long dwell,short drift,magnetohydrostatic centrifuge and method
FI882746A7 (fi) Hybridiproteiini C ja menetelmä sen valmistamiseksi.
DE3850592D1 (de) Apparat zur Vorbereitung von Briefen.
FI873572A7 (fi) Menetelmä eukaryoottiproteiinin ilmentymisen parantamiseksi.
DE3764026D1 (de) Verfahren zum aufbereiten von gebrauchten primaerzellen.
DE3668022D1 (de) Maschine zum herstellen von graeben im boden.
DE3773121D1 (de) Verfahren zum identifizieren gewebstypischer, unloeslicher cytoskelettproteine.
FI871607L (fi) Menetelmä peptidien valmistamiseksi, menetelmässä käyttökelpoinen yhdistelmäplasmidi ja plasmidilla transformoituja myeloomasoluja
EP0269895A3 (en) Liquid-filter, in particular for fuels
FI872310A7 (fi) Menetelmä indiumin, germaniumin ja/tai galliumin talteenottamiseksi.
GR3017286T3 (en) Mineral fine-pulverising method, and pulveriser for carrying out this method.
EP0309555A4 (en) IMMUNOGENIC POLYPEPTIDE AND ITS PURIFICATION METHOD.
FI850970A7 (fi) Menetelmä DL- -aryyliaminohappojen valmistamiseksi.
EP0271964A3 (en) Method for preparing protein hydrolysates soluble in an acid environment, and the hydrolysates obtained
FI853346A7 (fi) 3'-ilmaisua edistävät fragmentit ja menetelmä.
DE3774041D1 (de) Apparat zum handhaben von boegen.
AU563449B2 (en) Process for treating anestrus in ewes or beef cattle
FI874565A7 (fi) Metylotrofisissa mikro-organismeissa replikoituva hybridiplasmidi ja menetelmä sen valmistamiseksi.
EP0172917A4 (en) IMMUNODEFICIENCY TREATMENT AGENTS, THEIR TREATMENT PROCESS AND THEIR USE.